Curaleaf Q1 Revenue Comes In At $75.1M

Cannabis operator Curaleaf Holdings, Inc. CURACURLF reported first quarter revenue of $75.1 million, a year-to-year increase of 260 percent.

Curaleaf opened seven new dispensaries in key markets such as Florida, Maryland and New York, building on existing licenses and prior acquisitions.

Curaleaf recently acquired Select, a cannabis wholesale brand; It completed the acquisition of exclusive rights to operate Absolute Healthcare's Emerald dispensary in Arizona; And the company also completed the acquisition of Eureka Investment Partners in California.

"We reported strong organic growth, anchored by our core East Coast markets, and announced several landmark transactions, including the acquisition of Select, that will position Curaleaf to lead the industry forward,” said CEO Joseph Lusardi in a press release.

“The combination of Curaleaf and Select will bring together the largest retailer and largest wholesaler, with the leading wellness and lifestyle brands in the United States, providing substantial opportunities to accelerate revenue growth, achieve significant cost savings and expand overall margins."

Curaleaf's stock traded at $8.25 per share at time of publication.

Related Links:

Curaleaf To Buy 'Select' Brand Owner Cura Partners In $948M Deal

Curaleaf Signs Agreement To Acquire Eureka Investment Partners

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsMarkets
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.